Carl Bjartmar appointed as CMO for Ascelia... Ascelia Pharma announced on Friday Spetember 14 that Carl Bjartmar, MD, PhD, has been appointed as new Chief Medical Officer (CMO) for Ascelia Pharma. Carl has most recently worked as CMO for Wilson … more ➔
Torbjørn Furuseth joins Targovax as CFOTargovax ASA (Targovax or the Company; OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, announces the appointment of Dr. Torbjørn … more ➔
Johanna Ivaska joins Orion CorporationJohanna Ivaska, Academy Professor of Biochemistry has been appointed Head & Vice President of Oncology Research in Orion Corporation as of 1 October 2018. Ivaska joins Orion from the University … more ➔
F-star Appoints Nessan Bermingham as Chair...F-star, a biopharmaceutical company developing novel bispecific antibodies, today announces the appointment of Nessan Bermingham, Ph.D. as Chairman of its Board of Directors. Nessan succeeds John Edwards … more ➔
Crescendo Biologics appoints new CMOCrescendo Biologics Ltd (Crescendo), today announced that Pavel Pisa, MD, PhD, has been appointed as Chief Medical Officer of the Company with immediate effect. more ➔
Changes at Arix BioscienceArix Bioscience, a healthcare and life science company, today announces planned changes to its executive team to prepare for its next phase of growth and development. Dr Joe Anderson, who has served … more ➔
New Secretary General & Directors at...EuropaBio today confirmed the appointment of Joanna Dupont-Inglis as its new Secretary General. Commenting on this promotion, EuropaBio chair, Tjerk de Ruiter, said Joanna has an excellent track record … more ➔
Changes at Roche – Diagnostics CEO t...Roche today announced that Roland Diggelmann, CEO Diagnostics Division and member of the Corporate Executive Committee, will be leaving Roche to pursue his career outside of the company effective 30 … more ➔
Congenica Appoints Wendy Britten as CFOCongenica today announced the appointment of Mrs Wendy Britten as its new Chief Financial Officer (CFO), effective 1st September, 2018. Mrs Britten will have overall control and responsibility for all … more ➔
Greg Rush joins Parexel as Executive VP &#...Parexel International Corporation today announced the appointment of Greg Rush as Executive Vice President and Chief Financial Officer. more ➔
